Dirk Kersten, Director at Dyne Therapeutics, Inc. (DYN), sold 160,586 shares at $35.74 ($5.8M) on 2024-09-19, disclosed to the SEC on 2024-09-20.
Scheduled sale ($5.8M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.03 | 1,554 | $54K | 0.9% |
| 2 | $35.03 | 1,554 | $54K | 0.9% |
| 3 | $35.74 | 27,767 | $992K | 17.1% |
| 4 | $35.74 | 27,767 | $992K | 17.1% |
| 5 | $36.41 | 50,972 | $1.9M | 32.0% |
| 6 | $36.41 | 50,972 |
| $1.9M |
| 32.0% |
| Total | $36.15 avg | 160,586 | $5.8M | 100% |
| Filing → |
| DYN | SELL | 2026-06-22 | $1.7M | — | Filing → |
| DYN | SELL | 2026-04-23 | $219K | — | Filing → |
| DYN | SELL | 2026-04-21 | $6.8M | — | Filing → |